Synthetic Biologics Reports Year End 2013 Financial Results and Operational …

Published April 1, 2014

Synthetic Biologics Reports Year End 2013 Financial Results and Operational …
Patients in the Phase II clinical trial evaluating Synthetic Biologics' drug candidate, Trimesta™, in combination with Teva's Copaxone® (glatiramer acetate injection) for the treatment of RRMS under an investigator-initiated IND, completed their final …
Read more on SYS-CON Media (press release)

Amarantus Appoints Dr. Louis Kirby to Board of Advisors
He previously founded Pivotal Research Centers, which became one of the nation's largest free-standing private clinical research operations, before being sold in 2005 to a public company. Dr. Kirby … Dr. Kirby obtained his undergraduate degree in …
Read more on GlobeNewswire (press release)

Benchmark Recovery Center – Mark Houston Hall Meeting – Addiction Treatment works. — Addiction treatment News – Every 2nd Saturday of the month BRC Residents and families get together at the Mark Houston Hall for a BBQ, fellowship and a messa…

Find More Austin Texas Drug Treatment Centers Information…